The Role of Serum Level of Indoleamine 2,3–dioxygenase 1 (IDO1) in Patients with Prostate Cancer. Medico Legal Update, [S. l.], v. 21, n. 2, p. 1402–1407, 2021. DOI: 10.37506/mlu.v21i2.2888. Disponível em: https://ijop.net/index.php/mlu/article/view/2888. Acesso em: 20 may. 2026.